H3K27 Methylation Dynamics during CD4 T Cell Activation: Regulation of JAK/STAT and IL12RB2 Expression by JMJD3

J Immunol. 2017 Nov 1;199(9):3158-3175. doi: 10.4049/jimmunol.1700475. Epub 2017 Sep 25.

Abstract

The changes to the epigenetic landscape in response to Ag during CD4 T cell activation have not been well characterized. Although CD4 T cell subsets have been mapped globally for numerous epigenetic marks, little has been done to study their dynamics early after activation. We have studied changes to promoter H3K27me3 during activation of human naive and memory CD4 T cells. Our results show that these changes occur relatively early (1 d) after activation of naive and memory cells and that demethylation is the predominant change to H3K27me3 at this time point, reinforcing high expression of target genes. Additionally, inhibition of the H3K27 demethylase JMJD3 in naive CD4 T cells demonstrates how critically important molecules required for T cell differentiation, such as JAK2 and IL12RB2, are regulated by H3K27me3. Our results show that H3K27me3 is a dynamic and important epigenetic modification during CD4 T cell activation and that JMJD3-driven H3K27 demethylation is critical for CD4 T cell function.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • CD4-Positive T-Lymphocytes / immunology*
  • Epigenesis, Genetic / immunology
  • Gene Expression Regulation, Enzymologic / immunology*
  • Histones / immunology*
  • Humans
  • Janus Kinase 2 / immunology*
  • Jumonji Domain-Containing Histone Demethylases / immunology*
  • Lymphocyte Activation*
  • Methylation
  • Protein Processing, Post-Translational / immunology*
  • Receptors, Interleukin-12 / immunology*
  • STAT Transcription Factors / immunology*

Substances

  • Histones
  • IL12RB2 protein, human
  • Receptors, Interleukin-12
  • STAT Transcription Factors
  • Jumonji Domain-Containing Histone Demethylases
  • KDM6B protein, human
  • JAK2 protein, human
  • Janus Kinase 2